BriaCell Therapeutics Cor... (BCTX)
NASDAQ: BCTX
· Real-Time Price · USD
11.01
0.30 (2.80%)
At close: Sep 26, 2025, 11:08 AM
2.80% (1D)
| Bid | 7.84 |
| Market Cap | 19.32M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -19.43M |
| EPS (ttm) | -76.9 |
| PE Ratio (ttm) | -0.14 |
| Forward PE | -0.67 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 13.92 |
| Volume | 28,155 |
| Avg. Volume (20D) | 134,239 |
| Open | 10.75 |
| Previous Close | 10.71 |
| Day's Range | 10.70 - 11.11 |
| 52-Week Range | 3.50 - 98.20 |
| Beta | 1.47 |
| Ex-Dividend Date | n/a |
About BCTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.61%
BriaCell Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
2 months ago
-61.78%
BriaCell Therapeutics shares are trading lower after the company announced the pricing of a $15 million offering of 12 million units at $1.25 per unit.
